CN Patent

CN101970410B — 吡啶基氨基乙酸化合物

Assigned to Ube Corp · Expires 2014-06-25 · 12y expired

What this patent protects

本发明提供一种下述通式(1)表示的新型吡啶基氨基乙酸化合物或其药理学上可容许的盐，下式中，R 1 、R 2 、R 3 、Y和Z如说明书和权利要求书中所定义。该吡啶基氨基乙酸化合物由于具有EP2激动作用，因此能够用作例如哮喘或慢性阻塞性肺疾病等呼吸系统疾病的治疗药和/或预防药。。

USPTO Abstract

本发明提供一种下述通式(1)表示的新型吡啶基氨基乙酸化合物或其药理学上可容许的盐，下式中，R 1 、R 2 、R 3 、Y和Z如说明书和权利要求书中所定义。该吡啶基氨基乙酸化合物由于具有EP2激动作用，因此能够用作例如哮喘或慢性阻塞性肺疾病等呼吸系统疾病的治疗药和/或预防药。。

Drugs covered by this patent

omidenepag-isopropyl (OMIDENEPAG ISOPROPYL)

Patent Metadata

Patent number: CN101970410B
Jurisdiction: CN
Classification: —
Expires: 2014-06-25
Drug substance claim: No
Drug product claim: No
Assignee: Ube Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.